Skip to main content

Table 1 Characteristics of 31 patients with synchronous RCC and other solid malignancies

From: Multi-detector computed tomography (MDCT) evaluation of synchronous renal cell carcinoma and other solid malignancies

Case No Age/sex Renal cell carcinoma Extra-renal malignancy
TNM staging Site TNM staging
T N M Stage T N M Stage
1 58/M T1a N0 M0 I HCC B (BCLC)    
2 67/M T1b N0 M0 I HCC B (BCLC)    
3 58/M T1b N0 M0 I HCC B (BCLC)    
4 65/M T3a N0 M0 III HCC C (BCLC)    
5 55/F T1a N0 M0 I HCC A (BCLC)    
6 56/F T1a N0 M0 I HCC A (BCLC)    
7 58/F T1a N0 M0 I HCC A (BCLC)    
8 73/M T1a N0 M0 I HCC A (BCLC)    
9 64/M T3a N0 M0 III HCC A (BCLC)    
10 68/M T1a N0 M0 I HCC A (BCLC)    
11 45/F T1a N0 M0 I Breast T2 N0 M0 IIA
12 55/F T1b N0 M0 I Breast T4b N1 M0 IIIC
13 63/F T1b N0 M0 I Breast T1c N0 M0 I
14 65/F T1b N0 M0 I Breast T2 N0 M0 IIA
15 60/F T1b N0 M0 I NHL I (Ann Arbor staging)    
16 65/F T3a N0 M0 III NHL III (Ann Arbor staging)    
17 53/M T1b N0 M0 I NHL II (Ann Arbor staging)    
18 62/M T1a N0 M0 I NHL III (Ann Arbor staging)    
19 63/M T1a N0 M0 I Lung T1b N2 M0 IIIA
20 70/M T1a N0 M0 I Lung T4 N0 M0 IIIA
21 52/M Local recurrent with para-aortic malignant LN     Lung T4 N2 M0 IIIB
22 68/F T1a N0 M0 I Colon T4a N1b M0 IIIB
23 68/M T1b N0 M0 I Colon T4a N1b M0 IIIB
24 58/M T1a N0 M0 I Colon T4a N2b M0 IIIC
25 73/M T1a N0 M0 I Prostate T3b N1 M1a IV
26 80/M T1b N0 M0 I Prostate T2b N0 M0 IIA
27 75/M T1a N0 M0 I U.B T3b N2 M0 IV
28 74/M T1a N0 M0 I Peri-ampullary T1 N0 M0 IA
29 73/M T1b N0 M0 I Mucoepidermoid* T0 N2 M0 IVA
30 75/M T1a N0 M0 I Skin Sq.C.C T1 N0 M0 I
31 36/M T3a N0 M0 III M.H.E* Locally advanced    
  1. BCLC; Barcelona Clinic Liver Cancer staging classification, HCC; Hepatocellular carcinoma, NHL; Non-Hodgkin lymphoma, M.H.E*; Malignant hemangioendothelioma, Mucoepidermoid*; Mucoepidermoid carcinoma of left upper cervical region. RCC; Renal cell carcinoma, Sq.C.C.; Squamous cell carcinoma, U.B.; Urinary bladder